Literature DB >> 24647781

Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine Differentiation.

Giordano Savelli1, Alberto Zaniboni2, Francesco Bertagna3, Giovanni Bosio3, Lutfun Nisa3, Carlo Rodella3, Giorgio Biasiotto3, Giovanni Bettinsoli3, Elena Migliorati3, Alessia Peli3, Roberta Falchi1, Francesca Giuffrida1, Raffaele Giubbini3.   

Abstract

BACKGROUND: Breast cancer (BC) is the most frequent cancer in European women with nearly 30% of the patients eventually developing metastases. Neuroendocrine differentiation is a rare event, but overexpression of somatostatin receptors in BC has been reported in many studies. CASE REPORT: A patient with liver metastases from BC was treated with peptide receptor radionuclide therapy (PRRT). Computed tomography scan and biochemical examinations showed a clear response to radionuclide therapy.
CONCLUSION: PRRT may be useful in metastatic BC patients.

Entities:  

Keywords:  Peptide receptors; Radionuclide therapy

Year:  2012        PMID： 24647781      PMCID： PMC3518936          DOI： 10.1159/000343612

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


  16 in total

1.  Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization.

Authors:  J C Reubi; J C Schaer; B Waser; G Mengod
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

2.  Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography.

Authors:  J C Schaer; B Waser; G Mengod; J C Reubi
Journal:  Int J Cancer       Date:  1997-03-04       Impact factor: 7.396

3.  Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors.

Authors:  Yusuf Menda; M Sue O'Dorisio; Simon Kao; Geetika Khanna; Stacy Michael; Mary Connolly; John Babich; Thomas O'Dorisio; David Bushnell; Mark Madsen
Journal:  J Nucl Med       Date:  2010-09-16       Impact factor: 10.057

4.  The relationship between somatostatin, epidermal growth factor, and steroid hormone receptors in breast cancer.

Authors:  J C Reubi; J Torhorst
Journal:  Cancer       Date:  1989-09-15       Impact factor: 6.860

5.  Correlative study on neuro-endocrine differentiation and presence of somatostatin receptors in breast carcinomas.

Authors:  M Papotti; L Macrí; G Bussolati; J C Reubi
Journal:  Int J Cancer       Date:  1989-03-15       Impact factor: 7.396

6.  Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters.

Authors:  Gary M K Tse; Tony K F Ma; Winnie C W Chu; Wynnie W M Lam; Cycles S P Poon; Wing-Cheong Chan
Journal:  Mod Pathol       Date:  2004-05       Impact factor: 7.842

7.  111In-octreotide scintigraphy in oncology.

Authors:  E P Krenning; D J Kwekkeboom; J C Reubi; P M van Hagen; C H van Eijck; H Y Oei; S W Lamberts
Journal:  Digestion       Date:  1993       Impact factor: 3.216

8.  Successful targeted radiotherapy with 90Y-DOTATOC in a patient with Merkel cell carcinoma. A Case Report.

Authors:  G Meier; C Waldherr; R Herrmann; H Maecke; J Mueller-Brand; M Pless
Journal:  Oncology       Date:  2004       Impact factor: 2.935

9.  Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma.

Authors:  F Forrer; I Riedweg; H R Maecke; J Mueller-Brand
Journal:  Q J Nucl Med Mol Imaging       Date:  2008-05-16       Impact factor: 2.346

10.  Somatostatin-receptor scintigraphy in primary breast cancer.

Authors:  C H van Eijck; E P Krenning; A Bootsma; H Y Oei; R van Pel; J Lindemans; J Jeekel; J C Reubi; S W Lamberts
Journal:  Lancet       Date:  1994-03-12       Impact factor: 79.321
View more
  11 in total

Review 1.  Molecular Imaging in Breast Cancer.

Authors:  Daniela Miladinova
Journal:  Nucl Med Mol Imaging       Date:  2019-10-16

Review 2.  [Neuroendocrine neoplasms of the breast].

Authors:  M Anlauf; M Neumann; S Bomberg; K Luczak; S Heikaus; C Gustmann; C Antke; S Ezziddin; C Fottner; M Pavel; U-F Pape; A Rinke; H Lahner; M Schott; B Cremer; D Hörsch; R P Baum; U Groh; I Alkatout; C Rudlowski; P Scheler; T K Zirbes; J Hoffmann; T Fehm; H E Gabbert; S E Baldus
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

3.  Dramatic response to cyclin D-dependent kinase 4/6 inhibitor in refractory poorly differentiated neuroendocrine carcinoma of the breast.

Authors:  Allison Shanks; Julia Choi; Vinit Karur
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-09

Review 4.  Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives.

Authors:  Alessandro Inno; Giuseppe Bogina; Monica Turazza; Laura Bortesi; Simona Duranti; Alberto Massocco; Giuseppe Zamboni; Giovanni Carbognin; Filippo Alongi; Matteo Salgarello; Stefania Gori
Journal:  Oncologist       Date:  2015-12-09

5.  Prognostic factors of primary neuroendocrine breast cancer: A population-based study.

Authors:  Shu-Tao Ma; Ding-Yuan Wang; Yi-Bing Liu; Hui-Jing Tan; Yue-Yue Ge; Yihebali Chi; Bai-Lin Zhang
Journal:  Cancer Med       Date:  2022-05-02       Impact factor: 4.711

6.  Incidental primary breast cancer detected on surveillance 68Ga-DOTATATE PET/CT in a patient with metastatic neuroendocrine carcinoma.

Authors:  Emily B Ambinder; Rudolf A Werner; Steven P Rowe
Journal:  Radiol Case Rep       Date:  2020-06-25

Review 7.  Neuroendocrine breast carcinoma: a rare but challenging entity.

Authors:  Elena Trevisi; Anna La Salvia; Lorenzo Daniele; Maria Pia Brizzi; Giovanni De Rosa; Giorgio V Scagliotti; Massimo Di Maio
Journal:  Med Oncol       Date:  2020-07-25       Impact factor: 3.064

Review 8.  Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues.

Authors:  Marco Gallo; Severo Campione; Valentina Di Vito; Nicoletta Fortunati; Fabio Lo Calzo; Erika Messina; Rosaria Maddalena Ruggeri; Antongiulio Faggiano; Annamaria Anita Livia Colao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-26       Impact factor: 5.555

Review 9.  Neuroendocrine Neoplasms of the Breast: The Latest WHO Classification and Review of the Literature.

Authors:  Yukinori Ozaki; Sakiko Miura; Ryosuke Oki; Teppei Morikawa; Keita Uchino
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

Review 10.  Neuroendocrine Cancer of the Breast: A Rare Entity.

Authors:  Azzurra Irelli; Maria Maddalena Sirufo; Luca Morelli; Carlo D'Ugo; Lia Ginaldi; Massimo De Martinis
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.